UNITED THERAPEUTICS Corp 4

United Therapeutics Corp non-employee director Linda Maxwell received an annual equity award of 380 restricted stock units and 1,190 stock options on July 22, 2026.

On July 22, 2026, United Therapeutics Corp non-employee director Linda Maxwell received an annual equity compensation package consisting of 380 restricted stock units and 1,190 stock options, each RSU and option corresponding to one share of common stock. The RSUs have no exercise price and will vest in full on the earlier of the one-year anniversary of the grant date or the anticipated June 25, 2027 annual shareholders meeting. The stock options carry an exercise price of $527.07 per share and are scheduled to vest on the same June 25, 2027 date, with an expiration date of July 22, 2033. Following these awards, Maxwell directly holds 380 RSUs (convertible into common stock upon vesting) and 1,190 options, representing routine non-employee director compensation rather than an open-market purchase or sale.

Filing Facts

CIK

1082554

Ticker

UTHR

Form

4

Source Type

fda

Accession

0001822674-26-000004

Alert Tier

5